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Abstract 
Saccharomyces cerevisiae is an efficient host for natural-compound production and 
preferentially employed in academic studies and bioindustries. However, S. cerevisiae 
exhibits limited production capacity for lipophilic natural products, especially 
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compounds that accumulate intracellularly, such as polyketides and carotenoids, with 
some engineered compounds displaying cytotoxicity. In this study, we used a 
nature-inspired strategy to establish an effective platform to improve lipid oil–
triacylglycerol (TAG) metabolism and enable increased lycopene accumulation. 
Through systematic traditional engineering methods, we achieved relatively 
high-level production at 56.2 mg lycopene/g cell dry weight (cdw). To focus on TAG 
metabolism in order to increase lycopene accumulation, we overexpressed key genes 
associated with fatty acid synthesis and TAG production, followed by modulation of 
TAG fatty acyl composition by overexpressing a fatty acid desaturase (OLE1) and 
deletion of Seipin (FLD1), which regulates lipid-droplet size. Results showed that the 
engineered strain produced 70.5 mg lycopene/g cdw, a 25% increase relative to the 
original high-yield strain, with lycopene production reaching 2.37 g/L and 73.3 mg/g 
cdw in fed-batch fermentation and representing the highest lycopene yield in S. 
cerevisiae reported to date. These findings offer an effective strategy for extended 
systematic metabolic engineering through lipid engineering. 
Keywords: Saccharomyces cerevisiae, systematic metabolic engineering, lipid 
engineering, triacylglycerol, lycopene 
1. Introduction 
Saccharomyces cerevisiae is an efficient and preferential chassis due to the ease of 
genetic manipulation and the availability of extensive knowledge regarding its 
physiology and biochemistry (Nevoigt, 2008). With the development of synthetic 
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biology, it has become an indispensable platform for the synthesis of various types of 
chemicals and natural products, some of which represent significant milestones (e.g., 
the drug precursor artemisinin and the biofuel farnesene) (Ajikumar et al., 2010; 
Meadows et al., 2016; Paddon et al., 2013). Lipophilic natural products comprise 
highly diverse classes of pharmaceuticals and nutraceuticals that include polyketides 
and carotenoids (Meadows et al., 2016; Tan & Liu, 2016). However, non-oleaginous S. 
cerevisiae species generally display low-production capacity for and are highly 
sensitive to lipophilic natural compounds, especially those that accumulate 
intracellularly (Xie et al., 2015). Synthetic production of such molecules through 
traditional metabolic engineering and up scaling has proven difficult in these model 
hosts. 
In nature, microbes have developed various strategies to cope with potentially 
toxic compounds. For example, small-molecule toxic and lipophilic products can be 
pumped from the cell interior to the extracellular space (Martinez et al., 2009; 
Nikaido & Vaara, 1985; Walsh, 2000), whereas large molecules are generally 
accumulated intracellularly in specialized compartments. The algae Haematococcus 
pluvialis can accumulate the antioxidative carotenoid astaxanthin in oil droplets 
(Wayama et al., 2013), with reported correlations between the lipid- and 
astaxanthin-biosynthesis pathways in H. pluvialis along with their dynamic 
‘co-evolution’ during fermentation (Li et al., 2017). Similarly, stimulation of lycopene 
synthesis in the fungus Blakeslea trispora is accompanied by changes in lipid 
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composition, with increases in both lipid content and the degree of desaturation 
degree of neutral-lipid fatty acids (Tereshina et al., 2010). These findings suggest that 
some microbes are capable of producing large amounts of oil, which can be stored in 
lipid droplets (LDs) in order to avoid their associated toxicity. Previous studies 
reported efforts to improve carotenoid synthesis in the oleaginous organism Yarrowia 
lipolytica, with Gao et al. (2017) reporting production of 4 g/L β-carotene in Y. 
lipolytica through traditional metabolic engineering. Additionally, Larroude et al. 
(2017) reported a positive correlation between β-carotene and lipid content following 
production of 6.5 g/L β-carotene in Y. lipolytica.  
LDs have a lipophilic core of neutral lipids that stores metabolic energy, thereby 
making them hubs for lipid metabolism. Triacylglycerols (TAGs) are water-insoluble 
fatty acid triesters of glycerol and the main LD components in most living organisms. 
In this study, we engineered a non-oleaginous S. cerevisiae host in order to increase 
the intracellular accumulation of lipophilic compounds by modulating TAG 
metabolism (Fig. 1). Lycopene was chosen as the intracellular lipophilic indicator, 
because it is a highly polyunsaturated lipophilic hydrocarbon toxic to cells at high 
concentrations (Klein-Marcuschamer et al., 2007; Verwaal et al., 2010), easily 
detectable, and a valuable compound in the food industry (Giovannucci et al., 1995; 
Rissanen et al., 2002). Using systematic traditional engineering methods, we 
established high-yield heterologous lycopene biosynthesis in S. cerevisiae. 
Additionally, context-based TAG-specific metabolic engineering was used to improve 
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TAG accumulation, modulate TAG composition, and regulate LD size, followed by 
analysis of the engineered strains to evaluate the effect of the lipid platform on 
lycopene accumulation. Our results confirmed the successful development of an 
oleaginous biorefinery platform in S. cerevisiae that enabled the efficient 
overproduction of the intracellular lipophilic natural product lycopene.  
 
2. Material and methods 
2.1. Plasmids and strains  
The strains used in this study are listed in Table 1. The primers used for fragments, 
and the fragments used for strain construction are listed in Tables S1 and S2, 
respectively. All fragments obtained by polymerase chain reaction were gel purified 
using a kit (Axygen; Corning Life Science, Corning, NY, USA) before cloning. Yeast 
cells were transformed using lithium acetate and PEG4000 (Gietz & Schiestl, 2007) 
for assembly cloning and gene deletion. Fragment assembly was performed using the 
Gibson method (Gibson, 2011) or yeast assembly (Gibson et al., 2008). 
 
2.2. Media and culture conditions  
S. cerevisiae CEN.PK2-1D was used as the background strain for all constructs, and 
Escherichia coli DH10B was used to propagate the recombinant plasmids. Engineered 
yeast strains were selected on synthetic complete medium [0.67% yeast nitrogen base 
with (NH4)2SO4, 2% glucose, and appropriate amino acids] under 
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auxotroph-screening conditions (uracil 20 mg/L, histidine 20 mg/L, tryptophan 20 
mg/L, and leucine 100 mg/L) or yeast extract–peptone–dextrose (YPD) medium (2% 
tryptone, 1% yeast extract, and 2% glucose) with antibiotic screening (G418 200 
mg/L and hygromycin 200 mg/L). All media were autoclaved at 115°C for 30 min 
before use. Lycopene standards were extracted from strain L3 and purified (Zhu et al., 
2015) (Fig. S1). 
For lycopene shake-flask fermentation, recombinant yeast colonies were 
inoculated into 5 mL YPD medium and cultured at 30°C on a rotary shaker (220 rpm) 
overnight. The seed broth (1%) was inoculated into 50 mL YPD medium. After 
pre-culturing, each seed culture was inoculated into 200 mL of YPDG medium (YPD 
medium with 1% galactose) in a 500-mL Erlenmeyer flask at an initial optical density 
at 600 nm (OD600) of 0.5 and grown at 30°C. Cells were harvested after 72 h or 96 h 
of cultivation. 
 
2.3. Lycopene extraction and titration  
For lycopene extraction, cells in 0.5 mL of culture were harvested by centrifugation at 
5,000 g for 5 min, and the supernatants were removed completely. Glass beads (0.2 g; 
0.5 mm in diameter) were added, followed by dispersal of the pellets by vortexing. 
The pellets were then extracted with acetone (using 1% butylated hydroxytoluene) by 
vortexing until residues were colorless, followed by centrifugation of solution at 
13,000 g for 10 min. The supernatant was transferred to sample vials for 
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high-performance liquid chromatography (HPLC) measurements, where the lycopene 
titer was calculated using a standard curve with an appropriate dilution factor and 
averaged over three replicates.  
An HPLC system (Dionex UltiMate 3000; Thermo Fisher Scientific, Waltham, 
MA, USA) equipped with a C18 column (4.6 × 150 mm,; 5 μm; Agilent Technologies, 
Santa Clara, CA, USA) was used to detect the 474-nm signal at 30°C. Samples were 
eluted with solvent A [90% aqueous acetonitrile (HPLC grade)] and solvent B [methyl 
alcohol-isopropyl alcohol (3:2, v/v; HPLC grade)] using the following gradient 
program at a flow rate of 1.0 mL/min: 0 to 15 min, 100% to 10% solvent A and 0% to 
90% solvent B; 15 to 30 min, 10% solvent A and 90% solvent B; and 30 to 35 min, 10% 
to 100% solvent A and 90% to 0% solvent B (Zhou et al., 2015). Data represent the 
means ± standard deviation (SD) of two or three biological replicates.  
 
2.4. TAG quantification and determination of TAG composition 
Cultured cells (0.5-mL culture) were harvested by centrifugation at 5,000 g for 5 min, 
and the supernatants were removed completely. Glass beads (0.2 g; 0.5 mm in 
diameter) were added, and the pellets were dispersed by vortexing. The pellets were 
then extracted with 1 mL of 1:1 (v/v) methanol and chloroform [with an internal 
standard of triheptadecanoylglycerol (Nu-chek-prep; Elysian, MN, USA)] by 
vortexing for 10 min. The mixture was then supplemented with 0.5 mL of ddH2O, 
vortexed for 5 min, and centrifuged at 13,000 g for 5 min. The upper water–methanol 
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layer was removed, and the lower chloroform layer containing the lipids was 
extracted again with 0.5 mL of methanol:chloroform (1:1, v/v) by vortexing for 10 
min, adding 0.25 mL of ddH2O, vortexing for 5 min, and centrifugation at 13,000 g 
for 5 min. Fifty microliters of the lower red-chloroform extract was applied to 
preparative thin-layer chromatography, where the components were separated by 
hexane/diethyl ether/acetic acid (70:30:1, v/v/v) and detected using iodine. The target 
TAG was collected from the silica-gel plate and washed with chloroform, followed by 
centrifugation of the solution at 13,000 g for 5 min. The supernatant was transferred 
into a new 2-mL Eppendorf tube, and the liquid was dried with nitrogen, after which 2 
mL of methanol (containing 5% sulfuric acid) and the mixture were heated at 90°C 
for 2 h in sealed test tubes. One milliliter of 0.9% NaCl was added to stop the reaction, 
and TAGs were extracted with 300 μL of hexane by mixing and centrifugation at 
13,000 g for 10 min, followed by transfer of the supernatant to sample vials for gas 
chromatography mass spectrometry (GC-MS) measurements. The GC-MS system 
(TSQ Quantum XLS; Thermo Fisher Scientific) was fitted with a TR-5MS capillary 
column (30 m × 0.25 mm × 0.25 μm; Thermo Fisher Scientific) and used helium as 
the carrier gas. An initial column temperature of 100°C was maintained for 3 min, 
after which it was increased at 10°C/min to 240°C and maintained for 8 min. The inlet 
temperature was set to 240°C. Data represent the means ± SD of two or three 
biological replicates. 
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2.5. Microscopic observation of lycopene distribution in yeast cells 
Strains were cultivated on YPDG agar medium at 30°C for 3 days, after which cells 
were scraped and diluted with 10 mM piperazine-N,N′-bis(2-ethanesulfonic acid) 
buffer. Images were acquired with an Ultra VIEW VoX confocal system (Perkin 
Elmer, Waltham, MA, USA) mounted on an Olympus IX81 microscope (Olympus, 
Tokyo, Japan). Fluorescence excitation was at 488 nm. 
 
2.6. Fed-batch fermentation of the lycopene-producing strain 
To create the seed culture, several single colonies of the lycopene-producing strain 
were grown in 5 mL YPD medium overnight at 30°C in a rotary shaker at 220 rpm, 
after which 1% of the seed culture was transferred to a 500-mL flask containing 200 
mL YPD and cultured at 30°C with shaking at 220 rpm for 16 h to 18 h. 10% of the 
seed culture was then inoculated into 3 L YPD medium in a 7-L fermenter for 
fed-batch fermentation at 30°C, with the pH maintained at 5.5 using 2 M NaOH. 
Fermentation was performed at an agitation speed of between 300 rpm and 600 rpm 
and an airflow rate ranging from 0.5 vvm to 2 vvm.  
We employed a two-stage fed-batch strategy. In the first stage, a feeding solution 
containing 500 g/L glucose and 15 g/L yeast extract was used to achieve rapid cell 
growth. Following decreases in glucose concentration to ~1 g/L in the batch culture, 
feeding was started in order to maintain the residual glucose concentration at between 
1 g/L and 2 g/L. When the cell mass began to slowly increase (to stationary phase), 
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the first stage was stopped, and the inducer galactose was added to a final 
concentration of 10 g/L. In the second stage, the feeding solution ethanol was used to 
produce lycopene, with the feeding rate adjusted in order to maintain the ethanol 
concentration at ~5 g/L. When the color of the culture changed, we detected the 
product in order to assess lycopene accumulation. When the lycopene concentration 
stopped increasing, fermentation was stopped. 
 
3. Results 
3.1. Traditional systematic metabolic engineering of lycopene biosynthesis in S. 
cerevisiae 
To construct a strain capable of high-level lipophilic compound production and 
accumulation, we developed a lycopene-overproducing S. cerevisiae strain via six 
traditional metabolic engineering steps (Fig. 2): 1) enhancement of the endogenous 
upstream mevalonate (MVA) pathway, 2) heterologous expression of 
lycopene-producing enzymes, 3) enhancement of acetyl-CoA-precursor production, 4) 
regeneration of the redox cofactor NADPH, 5) tuning of heterologous expression of 
lycopene-synthesis genes, and 6) knocking out functional-bypass genes that influence 
carotenoid accumulation. To allow effective control of lycopene production, the genes 
responsible for lycopene synthesis were placed under the control of the 
galactose-regulated GAL promoter. Genes encoding GAL1, GAL7, and GAL10 were 
deleted (gal1Δgal7Δgal10Δ) in order to employ the GAL promoter, because 
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gal1Δgal7Δgal10Δ strains do not utilize galactose. 
 
3.1.1. Engineering of the key step in the MVA pathway 
The MVA pathway provides precursors for the lycopene-synthesis pathway. 
Endogenous truncated 3-hydroxy-3-methylglutaryl coenzyme A reductase (tHMG1) 
(Donald et al., 1997), the key enzyme in the MVA pathway, was overexpressed to 
enhance biosynthesis of the precursor geranylgeranyl diphosphate (GGPP) for 
lycopene synthesis (Fig. 2). The engineered strain was called YZL141 (Table 1).  
 
3.1.2. Construction of the heterologous lycopene pathway 
S. cerevisiae does not naturally produce carotenoids. We established a heterologous 
lycopene pathway in strain YZL141 (Fig. 2) by genomic integration of genes 
encoding GGPP synthase (CrtE), phytoene synthase (CrtB), and phytoene desaturase 
(CrtI) from different sources. The resulting strain (YZL3184) in which gal1, gal7, and 
gal10 were deleted and overexpressing tHMG1 and crtE from Taxus x media (Ding et 
al., 2014), crtB from Pantoea agglomerans, and crtI from B. trispora (Chen et al., 
2016) produced 4.9 mg/g cell dry weight (cdw) lycopene after 72 h of shake-flask 
cultivation in YPDG medium. YZL3184 was the reference strain used for subsequent 
engineering steps. 
 
3.1.3. Engineering the supply of the acetyl-CoA precursor 
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Acetyl-CoA serves as the substrate for lycopene biosynthesis and a building block for 
the upstream pathway of fatty acid synthesis. In S. cerevisiae, activation of acetate is 
the only cytosolic route for producing acetyl-CoA. During growth on glucose, the 
high glycolytic flux is directed toward ethanol formation (Pronk et al., 1996); 
therefore, it is necessary to redirect the carbon flux from ethanol to acetyl-CoA in the 
cytosolic compartment. Overexpression of acetaldehyde dehydrogenase ALD6 (Shiba 
et al., 2007) and acetyl-CoA synthetase ACS from Salmonella enterica substantially 
increases target downstream flux. By combining this strategy with overexpression of 
alcohol dehydrogenase ADH2, the only step responsible for oxidizing ethanol to 
acetaldehyde (Chen et al., 2013)(Fig. 2), we directed ethanol toward acetyl-CoA 
production in strain TM303 engineered from strain YZL3184. This further improved 
lycopene production to 10.3 mg/g cdw. 
 
3.1.4. Engineering of NADPH generation 
Engineering metabolism by targeting redox cofactors, such as NADP(H), can be used 
to suppress anabolism (Matsuda et al., 2013). In S. cerevisiae, the NADH kinase 
POS5, which mediates the ATP-driven conversion of NADH to NADPH appears 
dominant (Outten & Culotta, 2003). In the present study, we overexpressed POS5 in 
order to promote intracellular generation of the cofactors in order to optimize 
metabolic output. The resulting strain (TM206) yielded 11.9 mg/g cdw lycopene, a 
two-fold increase relative to that of the reference strain YZL3184. 
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3.1.5. Tuning of heterologous crt expression in the downstream pathway 
To balance and optimize lycopene-biosynthetic flux, expression of the crt genes was 
tuned by adjusting the integrated copy numbers. When one additional copy of crtE 
and crtI were integrated, lycopene production in the resulting strain (YZL318496) 
increased to 26.5 mg/g cdw, a four-fold increase relative to that of the reference strain 
YZL3184 (more information in supplementary materials Fig. S2).  
 
3.1.6. Knockout of bypass-pathway genes to increase lycopene accumulation 
Previous studies suggest that deletion of certain genes in the bypass pathway can 
improve carotenoid overproduction. For example, knockout of ypl062w reportedly 
enhances carotenoid production by increasing intracellular acetyl-CoA, which 
enhances MVA-pathway flux and, consequently, lycopene production (Chen et al., 
2016). Moreover, knockout of exg1 promotes carotenoid production in yeast BY4741 
(Trikka et al., 2015). In the present study, we knocked out both ypl062w and exg1 in 
YZL3184 to construct strain TM115, which produced lycopene at 34.4 mg/g cdw.  
    Combining all of the strategies described resulted in generation of the 
lycopene-overproducing strain TM606, which produced 43.7 mg lycopene/g cdw, an 
8.9-fold increase relative to that of YZL3184. When the cultivation time was 
prolonged to 96 h, the yield reached 56.2 mg/g cdw (Fig. 3B), which exceeded that of 
previously reported yields in S. cerevisiae (Chen et al., 2016; Xie et al., 2014). 
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To investigate lycopene accumulation in yeast cells, each strain was observed by 
confocal microscopy. In the cells of strain YZL3184, we found that most of the 
lycopene accumulated in LDs (Fig. S3). Additionally, we observed that lycopene 
distribution differentiated between the various engineered strains, and that in TM606 
cells, lycopene was dispersed throughout the cytoplasm (Fig. 3C). 
 
3.2. Engineering of TAG biosynthesis to increase TAG content and lycopene 
accumulation 
As a lipophilic carotenoid, β-carotene accumulates in lipid bodies in Dunaliella algae 
(Katz et al., 1995). Additionally, the oleaginous yeast Y. lipolytica can accumulate up 
to 90 mg β-carotene/g cdw in dark-colored drops (Larroude et al., 2017). Similarly, in 
the present study, we observed that lycopene produced in S. cerevisiae accumulated in 
LDs (Fig. S3), and that increasing production resulted in lycopene dispersal 
throughout the cytoplasm. Because lipid production in S. cerevisiae is lower than that 
in oleaginous hosts, we hypothesized that lipid production aids in the accumulation of 
intracellular lipophilic products, such as lycopene, in microorganisms. To investigate 
the correlation between lipid and lycopene syntheses, we engineered the metabolism 
of TAG, the predominant neutral lipid of LD cores. 
 In S. cerevisiae, TAGs are synthesized from phosphatidic acid (PA) and 
diacylglycerol (DAG) by two key enzymes, phosphatidate phosphatase (PAP) and 
acyl-CoA:diacylglycerol acyltransferase (DGAT). PAP, encoded by PAH1, catalyzes 
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the conversion of PA into DAG, which is the crucial step in TAG synthesis (Oludotun 
et al., 2011). DGAT, encoded by DGA1, catalyzes DAG acylation, the final and only 
committed step in TAG biosynthesis (Sorger & Daum, 2003) (Fig. 2). The starting 
molecule of TAG biosynthesis, acetyl-CoA, is the central metabolite in fatty acid 
biosynthesis. Acetyl-CoA carboxylase (ACC1) is responsible for the carboxylation of 
acetyl-CoA to form malonyl-CoA, the first committed and critical step in fatty acid 
metabolism. The introduction of two point mutations in ACC1 at Ser659 and Ser1157 
results in a three-fold enhancement of ACC1 activity and increased total fatty acid 
content (Shi et al., 2014). Therefore, we engineered the high-yield 
lycopene-producing strain TM606 to overproduce TAGs by overexpressing the three 
key enzymes, endogenous PAH1, DGA1, and a mutated ACC1 variant encoding 
ACC1
S659AS1157A
, under the control of the strong constitutive promoters PPGK1 and 
PTEF1. The resulting strain (TM60656) displayed increased TAG production of 74.9 
mg/g cdw (Fig. 4D) and increased lycopene production of 61.7 mg/g cdw (Fig. 4B), 
with the lycopene in most of the TM60656 cells observed in droplets rather than 
dispersed throughout the cytoplasm (Fig. 4C). These results indicated that increasing 
TAG production significantly promoted increased lycopene accumulation. 
 
3.3. Engineering the production of unsaturated TAGs to increase lycopene 
accumulation 
The fatty acyl chains utilized in TAG biosynthesis are mainly derived from fatty acid 
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biosynthesis in lipid biosynthesis, with incorporation of different types of fatty acid 
chains ultimately determining TAG composition. A previous study reported that 
increasing the exogenous supply of unsaturated fatty acids (UFAs), such as oleic acid 
(C18:1) and palmitoleic acid (C16:1), can efficiently increase β-carotene 
accumulation (Sun et al., 2016). In the present study, we hypothesized that the types 
of fatty acid chains present in TAGs might affect lycopene solubility.  
The OLE1 gene encodes the 9 fatty acid desaturase, which is involved in UFA 
production in S. cerevisiae by catalyzing the insertion of a double bond between 
carbons nine and ten of the saturated fatty acyl substrates palmitoyl (C16:0)- and 
stearoyl (C18:0)-CoA to yield the monoenoic products palmitoleic (C16:l) and oleic 
(C18:l) acid (Stukeys et al., 1990). In the present study, we overexpressed endogenous 
OLE1 in strain TM60656 to produce TM70756, which generated 66.9 mg TAGs/g 
cdw. Moreover, we found that the UFA substrates of TAGs increased to 32.8 mg/g 
cdw, and lycopene accumulation increased to 63.7 mg/g cdw (Fig. 4B). These results 
indicated that enhancing UFA biosynthesis represents an efficacious strategy for 
improving the production of polyene-lipophilic products in recombinant S. cerevisiae. 
 
3.4. Deletion of FLD1 improves lycopene accumulation 
In addition to LD composition, regulating LD size represents another important 
strategy for enhancing lycopene accumulation in LDs. FLD1 regulates the cellular 
dynamics of LDs, and FLD1 deletion in S. cerevisiae increases lipid levels, LD 
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clustering, and the formation of enlarged LDs (Fei et al., 2008). Additionally, 
formation of “supersized” LDs up to 50-fold larger than the normal volume was 
observed in FLD1-depleted cells (Sorger & Daum, 2002). In the present study, FLD1 
deletion in strain TM70756 to create TM70456 resulted in increased TAG production 
at 73.5 mg/g cdw and increased lycopene accumulation to 70.5 mg/g cdw (Fig. 4B). 
And the cells harbored lycopene with a needle-like morphology (Fig. 4C). Our results 
indicated that we successfully developed an efficient lipid platform through 
manipulating TAG content and UFA composition and regulating LD size in a 
high-yield lycopene-producing strain, which resulted in a 25% increase in lycopene 
production. To the best of our knowledge, this represents the highest yield of lycopene 
in S. cerevisiae reported to date.  
 
3.5. High-density fermentation for lycopene production  
We used two stages of cell growth and product accumulation during high-density cell 
fermentation, with these stages separated by employing a modified GAL-regulation 
system and controlling the supply of the carbon source. After first-stage feeding, the 
biomass reached an OD600 of 98 after 28 h, with no observed changes in cell color. 
During the second feeding stage involving ethanol, we observed TAG accumulation 
initially increased, and decreased in mid-to-late stage of fermentation. Lycopene 
accumulation dramatically increased, although the biomass increased only slightly, 
and the morphology of lycopene in cells changed from small droplets to needle-like 
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structure. The results showed that lycopene accumulated continuously to 2.37 g/L and 
73.3 mg/g cdw until the completion of fermentation (Fig. 5). These results 
demonstrated the accumulation of lycopene content much higher than those reported 
previously in engineered S. cerevisiae strains (Chen et al., 2016; Xie et al., 2015) or in 
natural lycopene producers, such as tomato (Agarwal et al., 2001) and B. trispora 
(Mantzouridou & Tsimidou, 2008).  
4. Discussion  
The overproduction of the lipophilic natural product lycopene, which accumulates 
intracellularly upon overproduction in microbial hosts, is limited by cell-storage 
capacity or cell cytotoxicity, thereby hampering the up scaling of production 
processes. The TAG-rich chassis constructed in this study allowed high-yield 
overproduction of lycopene in S. cerevisiae. We developed a yeast platform by 
manipulating three main factors determining the production of TAGs, which form the 
core of LDs: overexpression of key genes associated with fatty acid synthesis and 
TAG production, engineering TAG composition, and regulating LD size. The platform 
showed a 25% increase in lycopene production relative to that of the high-yield strain 
used as the starting host. These findings showed that improving the lipid-biosynthesis 
network promoted increased production of intracellular lycopene in S. cerevisiae. 
Interestingly, we observed that the three steps in TAG engineering cooperated to 
determine TAG composition and content. Strain TM606, generated to study the 
relationship between TAG metabolism and lycopene production, produced 47.1 mg 
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TAGs/g cdw, with UFAs accounting for 21.9 mg/g cdw. In the first step of TAG 
engineering (TM60656), TAG content increased to 59%, whereas UFA composition 
comprised only 30% of the TAG profile, which was similar to that observed in the 
starting strain and implied that TAG production increased in this step primarily 
through enhanced synthesis of saturated fatty acids. Additionally, lycopene 
accumulation increased 10% (P < 0.05) during this step. Moreover, our use of a 
strategy involving overexpression of PAH1, DGA1, and the mutant form of ACC1 was 
based on a method described previously (Ferreira et al., 2018) and resulted in 
production of 129 mg TAG/g cdw. We speculated that the lycopene-biosynthesis 
pathway shared the same TAG precursor (acetyl-CoA), which resulted in lower TAG 
accumulation. In the second engineering step, UFA comprised 49% of the TAG 
profile (a 46% increase), whereas total TAG content decreased by 11% (P < 0.05), 
suggesting that overexpressing OLE1 in order to increase UFA content not only 
influenced TAG composition but also slightly decreased TAG accumulation; however, 
lycopene accumulation during this step also increased. This result suggested that the 
double-bond structure between UFAs and lycopene promoted lycopene accumulation 
in TAGs. Recently, it was also found that greater lipid unsaturation led to increased 
cellular respiratory activity (Budin et al 2018). In the third engineering step, FLD1 
deletion increased TAG accumulation by 10% increase (P < 0.05), resulting in an 11% 
(P < 0.05) increase in lycopene accumulation. Together, these findings suggested that 
lycopene accumulation correlated with TAG production.  
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Observation of lycopene microstructure in cells enables a deeper understanding 
of correlations between lipid-metabolism engineering and lycopene accumulation. In 
the traditional engineering steps, we were able to easily identify increases in 
lycopene-containing droplets following increased lycopene production, until the 
lycopene was ultimately dispersed throughout the cells. In the engineering steps 
focused on lipid metabolism in TM60656, we similarly observed the storage of 
lycopene in droplets accompanied by increased lycopene production. Moreover, in 
most of the cells of the highest yielding strain (TM70456), we observed intracellular 
needle-like structures similar to lycopene crystal structures (Fig. S4). For the 
TAG-biosynthesis network, we engineered only a few key steps in order to provide 
proof-of-concept results. Previous studies showed that engineering fatty acid 
synthesis and TAG metabolism in S. cerevisiae could result in a more efficient cell 
factory for oil production (Ferreira et al., 2018; Zhou et al., 2016). Notably, our 
results confirmed that lipophilic products that share the same precursors (such as 
acetyl-CoA) with TAG biosynthesis should be considered in order to balance the flux 
to both pathways. 
LDs in S. cerevisiae and other eukaryotes are considered reservoirs of energy and 
building blocks for lipid synthesis. The two most prominent neutral lipids, TAG and 
steryl esters (SEs), both contribute to the formation of LDs. A biophysical 
investigation revealed that individual neutral lipids strongly affect the internal 
structure of LDs, and that SEs form several ordered shells below the surface of the 
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phospholipid monolayer of LDs, whereas TAGs are more or less randomly packed in 
the center of LDs (Czabany et al., 2008). Although S. cerevisiae contains both TAG 
and SEs, we preliminarily explored the effects of TAGs on intracellular lycopene 
accumulation. Future studies should investigate whether SE content can be 
appropriately tuned in order to optimize LD formation, similar to that reported 
previously (Ferreira et al., 2018). 
FLD1 deletion can result in the accumulation of supersized LDs accompanied by 
increased TAG content defective lipolysis (Fei et al., 2008; Wolinski et al., 2011). In 
the present study, this strategy resulted in increased lycopene accumulation, as well as 
more cells harboring lycopene with a needle-like morphology similar to that of 
lycopene crystal structures. This suggested that supersized LDs provided an 
environment conducive to the formation of these structures, which also enhanced 
lycopene purification. A previous report noted that the FLD1-knockout phenotype 
decreases the life span of yeast (Fabrizio et al., 2010), which was confirmed in our 
results showing decreases in the OD600 values of the FLD1-knockout strain 
(TM70456) (Fig. S5). Future efforts at metabolic engineering might attempt other 
gene modification to increase LD size, such as overexpression of LDP1 (lipid droplet 
protein)(Zhu et al., 2015) in order to avoid the attenuated cell growth associated with 
FLD1 deletion. 
This study focused on TAGs as the primary LD component and correlations 
between TAG content, composition, and the regulation of LDs to with improved 
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lycopene accumulation. Compared with prior attempts targeting this pathway, our 
findings were the first describing lipid-metabolic engineer to promote lycopene 
overproduction in a non-oleaginous organism. The industrialization of any product in 
the field of metabolic engineering is determined by titer, yield, productivity, content, 
purification ability, biosafety, and market acceptance. Oleaginous organism, such as Y. 
lipolytica, can produce excessive lipids for high production of -carotene (Larroude et 
al. 2017) while avoiding toxicity from carotenoid accumulation. The present study 
optimized lipid production in order to improve lycopene accumulation, resulting in 
73.3 mg/g cdw and 2.37 g/L lycopene, which represents the highest yield reported to 
date in oleaginous organisms or in S. cerevisiae, despite lycopene exhibiting higher 
toxicity than β-carotene. Oleaginous organisms use large quantities of glucose during 
lipid production, therefore, we implemented lipid production in S. cerevisiae by 
managing the efficient transfer of glucose toward pathways associated with lipid and 
lycopene production, thereby avoiding excessive lipid production due higher 
consumption of glucose and promoting a more energy efficient process. The optimal 
strain (TM70456) producing lycopene in needle-like structures enabled easier 
purification following the fermentation stage, thereby potentially decreasing the cost 
of separation of lycopene from large amounts of lipids in oleaginous organisms during 
industrial production. We believe that our strategy supports the use of non-oleaginous 
organisms for industrial production of such products.  
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Table 1. Strains and plasmids used in this study. 
Strain Host 
strain 
Description Source 
S. cerevisiae 
CEN.PK2-1D 
 MATα, ura3-52, trp1-289, leu2-3,112, 
his3Δ1, MAL2-8C, SUC2 
EUROSC
ARF 
L3 E. coli 
BL21(D
E3) 
PLac-AtoB-ERG13-tHMG1 
PLac-ERG12-ERG8-MVD1-Idi 
PT7-CrtE-CrtB-CrtI-Idi 
(Zhu et al., 
2015) 
YZL141 CEN.PK
2-1D 
gal1Δ, gal7Δ, gal10Δ:: 
TRP1_PGAL10-tHMG1  
This study 
YZL3184 YZL141 leu2Δ:: LEU2_PGAL1-TmCrtE 
ura3Δ:: HIS3_ PGAL1-PaCrtB, 
PGAL10-BtCrtI  
This study 
YZL318496 YZL318
4 
YPRCdelta15Δ:: KanMX_PGAL7-BtCrtI, 
PGAL10-TmCrtE  
This study 
TM206 YZL318
4 
XI-3Δ:: KanMX_PGAL1-POS5  This study 
TM303 YZL318
4 
X-3Δ:: HphMX_PGAL1-ADH2, 
PGAL10-SeACS, PGAL7-ALD6 
This study 
TM115 YZL318
4 
ypl062wΔ:: HphMX 
exg1Δ:: KanMX 
This study 
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TM606 YZL318
496 
XI-3Δ:: PGAL1-POS5 
X-3Δ:: PGAL1-ADH2, PGAL10-SeACS, 
PGAL7-ALD6  
ypl062wΔ:: HphMX 
exg1Δ:: KanMX 
This study 
TM60656 TM606 X-4Δ:: HphMX_PPGK1-PAH1, 
PTEF1-DGA1 
X-2Δ:: KanMX_PTEF1-ACC1
S659A, S1157A
 
This study 
TM70756 TM6065
6 
XII-2Δ:: HphMX_PPGK1-OLE1  This study 
TM70456 TM7075
6 
fld1Δ:: HphMX_PPGK1-OLE1 This study 
 
 
Fig. 1. Lycopene biosynthesis in S. cerevisiae. S. cerevisiae takes up glucose from the 
extracellular environment, and glucose metabolism results in acetyl-CoA 
accumulation and the release of NADPH. For lycopene production, acetyl-CoA is 
used in the endogenous MVA pathway and heterologous carotenoid pathway. 
Lycopene is distributed in lipid structures (e.g., phospholipid membranes and LDs). 
For TAG production, acetyl-CoA is used for endogenous fatty acid biosynthesis. 
TAGs are incorporated into LDs to store energy and dissolve lycopene crystals. 
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Purple spheres represent glucose particles, pink spheres represent galactose, green 
spheres represent NADPH, and blue spheres represent LDs. Dotted lines represent 
multiple reactions. 
 
Fig. 2. Simplified schematic representation of key fluxes in lycopene biosynthesis 
coupled with TAG metabolism in S. cerevisiae. The acetyl-CoA-producing pathway is 
highlighted in a yellow rectangle. Reactions associated with TAG synthesis are 
highlighted in a red rectangle. Lycopene-biosynthetic flux is highlighted in a green 
rectangle.  
PDC, pyruvate decarboxylase; ADH2, alcohol dehydrogenase; ALD6, acetaldehyde 
dehydrogenase; ACS, acetyl-CoA synthetase; tHMG1, truncated 
3-hydroxy-3-methylglutaryl-CoA reductase; CrtE, geranylgeranyl diphosphate 
synthase; CrtB, phytoene synthase; CrtI, phytoene desaturase; ACC1, acetyl-CoA 
carboxylase; FAS, fatty acyl-CoA synthetases; PAP, phosphatidate phosphatase; 
DGAT, acyl-CoA: diacylglycerol acyltransferase. HMG-CoA, 
3-hydroxy-3-methyl-glutaryl-CoA; IPP, isopentenyl diphosphate; DMAPP, 
dimethylallyl diphosphate; FPP, farnesyl diphosphate; GGPP, geranylgeranyl 
diphosphate; PA, phosphatidic acid; PLs, phospholipids; DAG, diacylglycerol; TAG, 
triacylglycerol.  
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Fig. 3. Steps of traditional systematic metabolic engineering of lycopene synthesis. (A) 
Traditional metabolic engineering strategies. (B) Accumulation of lycopene in 
different strains. *P < 0.05; **P < 0.01; ***P < 0.001 (Student’s t-test: two-tailed, 
two-sample equal variance). (C) Lycopene distribution in strains exhibiting different 
levels of accumulation. Results in the presence (right) and absence (left) of 
fluorescence excitation at 488 nm.  
 
Fig. 4. Metabolic engineering of lipid synthesis in the lycopene-producing strain 
TM606. (A) Lipid metabolic engineering strategies. (B) Lycopene accumulation. (C) 
Lycopene distribution in strains exhibiting different levels of accumulation. Results in 
the presence (right) and absence (left) of fluorescence excitation at 488 nm. (D) TAG 
accumulation. (E) Increased UFA composition in TAGs. *P < 0.05; **P < 0.01. 
(Student’s t-test: two-tailed, two-sample equal variance). 
 
Fig. 5. High-density fermentation for lycopene production. Time courses showing 
changes in cell growth, lycopene and TAG production, and the micro-morphology of 
TM70456 cells during fed-batch fermentation.  
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Highlights 
 
1. Improving triacylglycerol metabolism can increase lipophilic compounds 
accumulation. 
2. Increasing unsaturated fatty acyl composition of TAG can increase lycopene 
accumulation. 
3. FLD1, which regulates lipid droplet size, can increase lycopene accumulation in S. 
cerevisiae. 
4. A high lycopene content engineering S. cerevisiae strain which can produce 73.3 
mg/g cdw was constructed. 
5. The titer 2.37 g/L lycopene was achieved in the fed-batch fermentation, the highest 
titer in S. cerevisiae reported to date. 
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